CTx-2103

N/A

Report date: 2023/04/02 21:28:31
NME

Base Information

Drug NameCTx-2103
Drug Alias NameCTx2103
ClassificationSmall molecules
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCingulate Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCingulate Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A